@prefix : <http://www.s-cubed.dk/ZDUMMYMED/V1#> .
@prefix pr: <http://www.assero.co.uk/Protocol#> .
@prefix isoC: <http://www.assero.co.uk/ISO11179Concepts#> .
@prefix isoT: <http://www.assero.co.uk/ISO11179Types#> .
@prefix isoR: <http://www.assero.co.uk/ISO11179Registration#> .
@prefix isoI: <http://www.assero.co.uk/ISO11179Identification#> .
@prefix bo: <http://www.assero.co.uk/BusinessOperational#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<http://www.s-cubed.dk/ZDUMMYMED/V1>
	rdf:type owl:Ontology ;
.
<http://www.assero.co.uk/EP#f893165e-0b3a-4fe9-b41e-2def81c0c700>
	rdf:type pr:Epoch ;
	isoC:label "Screening"^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#e699d1f9-4208-4c15-b0e0-735b23332a38>
	rdf:type pr:Epoch ;
	isoC:label "Double Blind Treatment"^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#52bd485a-2d24-42e8-b7bc-d7a93d59e6d7>
	rdf:type pr:Epoch ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:ordinal "3"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#0899dfab-c2ba-4820-8292-d201f7432263>
	rdf:type pr:Arm ;
	isoC:label "ZD CP"^^xsd:string ;
	pr:description "Regimen ZD, CP"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#de3d5aa8-1491-410e-a865-3b815724550b>
	rdf:type pr:Arm ;
	isoC:label "CP ZD"^^xsd:string ;
	pr:description "Regimen CP, ZD"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/ELE#aad7ca9c-bb4d-49ad-89bb-6720e7d19a41>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#0899dfab-c2ba-4820-8292-d201f7432263> ;
	pr:inEpoch <http://www.assero.co.uk/EP#f893165e-0b3a-4fe9-b41e-2def81c0c700> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
.
<http://www.assero.co.uk/ELE#ee24db2b-fa55-4e3f-8aab-e794a2a66a62>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#de3d5aa8-1491-410e-a865-3b815724550b> ;
	pr:inEpoch <http://www.assero.co.uk/EP#f893165e-0b3a-4fe9-b41e-2def81c0c700> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
.
<http://www.assero.co.uk/ELE#02df51f1-21ff-450d-b7c4-c874d9ca5559>
	rdf:type pr:Element ;
	isoC:label "DB Treatment"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#0899dfab-c2ba-4820-8292-d201f7432263> ;
	pr:inEpoch <http://www.assero.co.uk/EP#e699d1f9-4208-4c15-b0e0-735b23332a38> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#d747003a-9a8c-4c4c-bbda-4a5a38374040> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#5f2b6052-c8e5-4f89-9a00-98ede21436e2> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#8e4a3ea3-f134-42f1-b9c7-310fdb10a596> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#ffb5fb3a-61f3-4c71-a877-f266e07e172c> ;
.
<http://www.assero.co.uk/ELE#4879f13c-1ff7-4f44-b56f-91e8910e18dd>
	rdf:type pr:Element ;
	isoC:label "DB Treatment"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#de3d5aa8-1491-410e-a865-3b815724550b> ;
	pr:inEpoch <http://www.assero.co.uk/EP#e699d1f9-4208-4c15-b0e0-735b23332a38> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#d747003a-9a8c-4c4c-bbda-4a5a38374040> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#5f2b6052-c8e5-4f89-9a00-98ede21436e2> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#8e4a3ea3-f134-42f1-b9c7-310fdb10a596> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#ffb5fb3a-61f3-4c71-a877-f266e07e172c> ;
.
<http://www.assero.co.uk/ELE#98368619-8f7d-4327-883b-acbb156ddac5>
	rdf:type pr:Element ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#0899dfab-c2ba-4820-8292-d201f7432263> ;
	pr:inEpoch <http://www.assero.co.uk/EP#52bd485a-2d24-42e8-b7bc-d7a93d59e6d7> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#91568b50-6444-4177-960c-b13d5915e61a> ;
.
<http://www.assero.co.uk/ELE#3c6e9816-9190-4ee3-8b32-b4d21daaa269>
	rdf:type pr:Element ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#de3d5aa8-1491-410e-a865-3b815724550b> ;
	pr:inEpoch <http://www.assero.co.uk/EP#52bd485a-2d24-42e8-b7bc-d7a93d59e6d7> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#91568b50-6444-4177-960c-b13d5915e61a> ;
.
:PR
	rdf:type pr:Protocol ;
	isoC:label "ZDUMMYMED"^^xsd:string ;
	isoT:hasState :PR_RS ;
	isoT:hasIdentifier :PR_SI ;
	isoT:origin ""^^xsd:string ;
	isoT:changeDescription ""^^xsd:string ;
	isoT:creationDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoT:lastChangeDate "2021-03-12T16:47:12+01:00"^^xsd:dateTime ;
	isoT:explanatoryComment ""^^xsd:string ;
	pr:acronym "ZDUMMYMED"^^xsd:string ;
	pr:title "A 26 weeks, randomized, double-blind, comparator-controlled, cross-over group, Efficacy and Safety trial of once daily ZD 5mg oral, as add-on to Basal Insulin in Elderly (>60 years old) Type 2 Diabetes Mellitus patients with insufficient glycemic control."^^xsd:string ;
	pr:shortTitle "ZDUMMYMED"^^xsd:string ;
	pr:studyPhase :PR_TUC3 ;
	pr:studyType :PR_TUC4 ;
	pr:interventionModel :PR_TUC1 ;
	pr:masking :PR_TUC2 ;
	pr:forIndication <http://www.s-cubed.dk/IND_TYPE_2_DIABETES_MELLITUS/V1#IND> ;
	pr:inTa <http://www.s-cubed.dk/TA_M/V1#TA> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#0899dfab-c2ba-4820-8292-d201f7432263> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#de3d5aa8-1491-410e-a865-3b815724550b> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#f893165e-0b3a-4fe9-b41e-2def81c0c700> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#e699d1f9-4208-4c15-b0e0-735b23332a38> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#52bd485a-2d24-42e8-b7bc-d7a93d59e6d7> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#48350ee1-e727-4897-bed7-87f881dc32bb> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#6dfe7647-b08b-4c7f-9ae7-daebd183ddeb> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#f3397870-9334-435e-87ab-54bf742cae35> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#be7a882d-860a-4755-8eb2-4f37a2304e53> ;
.
:PR_RS
	rdf:type isoR:RegistrationState ;
	isoR:registrationStatus "Incomplete"^^xsd:string ;
	isoR:administrativeNote ""^^xsd:string ;
	isoR:effectiveDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:untilDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:unresolvedIssue ""^^xsd:string ;
	isoR:administrativeStatus ""^^xsd:string ;
	isoR:previousState "Incomplete"^^xsd:string ;
	isoR:multipleEdit "false"^^xsd:boolean ;
	isoR:byAuthority <http://www.assero.co.uk/RA#DUNS123456789> ;
.
:PR_SI
	rdf:type isoI:ScopedIdentifier ;
	isoI:identifier "ZDUMMYMED"^^xsd:string ;
	isoI:versionLabel ""^^xsd:string ;
	isoI:version "1"^^xsd:positiveInteger ;
	isoI:semanticVersion "0.1.0"^^xsd:string ;
	isoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;
.
:PR_TUC3
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "3"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66737/V42#C66737_C15602> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC4
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "4"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99077/V28#C99077_C98388> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC1
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "1"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99076/V55#C99076_C82639> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC2
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "2"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66735/V4#C66735_C15228> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
<http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724>
	rdf:type pr:Visit ;
	isoC:label "Baseline"^^xsd:string ;
	pr:shortName "Vis#01"^^xsd:string ;
.
<http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630>
	rdf:type pr:Visit ;
	isoC:label "Week 1"^^xsd:string ;
	pr:shortName "Vis#02"^^xsd:string ;
.
<http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13>
	rdf:type pr:Visit ;
	isoC:label "Week 6"^^xsd:string ;
	pr:shortName "Vis#03"^^xsd:string ;
.
<http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95>
	rdf:type pr:Visit ;
	isoC:label "Week 12"^^xsd:string ;
	pr:shortName "Vis#04"^^xsd:string ;
.
<http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb>
	rdf:type pr:Visit ;
	isoC:label "Week 18"^^xsd:string ;
	pr:shortName "Vis#05"^^xsd:string ;
.
<http://www.assero.co.uk/VI#50347305a9cc2e647f8a8e7487c9a46cefa1e690>
	rdf:type pr:Visit ;
	isoC:label "Week 24"^^xsd:string ;
	pr:shortName "Vis#06"^^xsd:string ;
.
<http://www.assero.co.uk/VI#897ded48a15c04d82654d57ae11bac9e9445f877>
	rdf:type pr:Visit ;
	isoC:label "End of Study"^^xsd:string ;
	pr:shortName "Vis#07"^^xsd:string ;
.
<http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4>
	rdf:type pr:Timepoint ;
	isoC:label "TP1"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_06ff463d-5eac-4797-8368-bf8a8f7284d4> ;
	pr:inVisit <http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724> ;
.
<http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197>
	rdf:type pr:Timepoint ;
	isoC:label "TP2"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_66bf70dc-fe7f-4811-aea6-ff053a94ba13> ;
	pr:inVisit <http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630> ;
.
<http://www.assero.co.uk/TP#d747003a-9a8c-4c4c-bbda-4a5a38374040>
	rdf:type pr:Timepoint ;
	isoC:label "TP3"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_a3ab6041-7767-43d0-be19-3a1b97027d8c> ;
	pr:inVisit <http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13> ;
.
<http://www.assero.co.uk/TP#5f2b6052-c8e5-4f89-9a00-98ede21436e2>
	rdf:type pr:Timepoint ;
	isoC:label "TP4"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_655f6c4a-b993-4833-89c2-7cd3b7d3bcef> ;
	pr:inVisit <http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95> ;
.
<http://www.assero.co.uk/TP#8e4a3ea3-f134-42f1-b9c7-310fdb10a596>
	rdf:type pr:Timepoint ;
	isoC:label "TP5"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_5870ace6-c6e5-46fd-ad11-87397ba7af51> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
.
<http://www.assero.co.uk/TP#ffb5fb3a-61f3-4c71-a877-f266e07e172c>
	rdf:type pr:Timepoint ;
	isoC:label "TP6"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_5870ace6-c6e5-46fd-ad11-87397ba7af51> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
.
<http://www.assero.co.uk/TP#91568b50-6444-4177-960c-b13d5915e61a>
	rdf:type pr:Timepoint ;
	isoC:label "TP7"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_5870ace6-c6e5-46fd-ad11-87397ba7af51> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
.
<http://www.assero.co.uk/IC#TPO_06ff463d-5eac-4797-8368-bf8a8f7284d4>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "0"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_66bf70dc-fe7f-4811-aea6-ff053a94ba13>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "604800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_a3ab6041-7767-43d0-be19-3a1b97027d8c>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "3628800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_655f6c4a-b993-4833-89c2-7cd3b7d3bcef>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "7257600"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_5870ace6-c6e5-46fd-ad11-87397ba7af51>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "10886400"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_38156e58-6862-4b10-8952-209b5efa0547>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "14515200"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_8008660a-4750-4b00-abd1-9ba529bfe966>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "15120000"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/PROBJ#48350ee1-e727-4897-bed7-87f881dc32bb>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ1"^^xsd:string ;
	pr:fullText "To assess the effect of Xanomeline Transdermal Therapeutic System (TTS) on the ADAS-Cog and CIBIC+ scores at Week 24 in participants with Mild to Moderate Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_1/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#88e2ac46-754e-4c47-863d-20b66a54295b> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#404ab718-5233-4219-9862-683566d4d96e> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#6dfe7647-b08b-4c7f-9ae7-daebd183ddeb>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ2"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_3/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#bb218d6c-4a29-4d07-8d63-77730cf6a830> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#f3397870-9334-435e-87ab-54bf742cae35>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ3"^^xsd:string ;
	pr:fullText "To document the safety profile of the xanomeline TTS."^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_4/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#cf07f730-8514-4a38-97e5-b681e74614dd> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#542884f9-7802-4d24-88e5-6cecabd2a5b9> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#92218e47-e938-4076-93d2-943374440c4f> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#ba3bf3d1-43d6-4206-8aee-9a7152fd1b9a> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#be7a882d-860a-4755-8eb2-4f37a2304e53>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ4"^^xsd:string ;
	pr:fullText "To assess the effect of xanomeline TTS on the measure of behavioral/neuropsychiatric symptoms in participants with  Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_5/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#ae4844fc-04f5-4f09-8ee6-71fac5c86a43> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#f8f300f5-cf62-4af3-b1cb-d77b8a945a74>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ5"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvements in activities of daily living. Improved scores on the Disability Assessment for Dementia (DAD) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_6/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#9d528894-b206-4dd0-8cfc-23970b7edf1c> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PREND#88e2ac46-754e-4c47-863d-20b66a54295b>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP1"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Alzheimer’s Disease Assessment Scale – Cognitive Assessment (ADAS-Cog) 14 total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_1/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#5f2b6052-c8e5-4f89-9a00-98ede21436e2> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8e4a3ea3-f134-42f1-b9c7-310fdb10a596> ;
.
<http://www.assero.co.uk/PREND#404ab718-5233-4219-9862-683566d4d96e>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP2"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Clinician’s Interview-Based Impression of Change plus caregiver input (CIBIC+)"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_2/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#5f2b6052-c8e5-4f89-9a00-98ede21436e2> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8e4a3ea3-f134-42f1-b9c7-310fdb10a596> ;
.
<http://www.assero.co.uk/PREND#bb218d6c-4a29-4d07-8d63-77730cf6a830>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP3"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
.
<http://www.assero.co.uk/PREND#cf07f730-8514-4a38-97e5-b681e74614dd>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP4"^^xsd:string ;
	pr:fullText "The proportion of participants with adverse events, serious adverse events (SAEs), and adverse events leading to study intervention discontinuation over the 24-week study intervention period"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_5/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#8e4a3ea3-f134-42f1-b9c7-310fdb10a596> ;
.
<http://www.assero.co.uk/PREND#542884f9-7802-4d24-88e5-6cecabd2a5b9>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP5"^^xsd:string ;
	pr:fullText "The change from baseline to Week 12 in continuous laboratory tests: Hepatic Function Panel"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_6/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#d747003a-9a8c-4c4c-bbda-4a5a38374040> ;
.
<http://www.assero.co.uk/PREND#92218e47-e938-4076-93d2-943374440c4f>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP6"^^xsd:string ;
	pr:fullText "The proportion of participants with abnormal (high or low) laboratory measures (urinalysis) during the postrandomization phase"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_7/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#d747003a-9a8c-4c4c-bbda-4a5a38374040> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#5f2b6052-c8e5-4f89-9a00-98ede21436e2> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8e4a3ea3-f134-42f1-b9c7-310fdb10a596> ;
.
<http://www.assero.co.uk/PREND#ba3bf3d1-43d6-4206-8aee-9a7152fd1b9a>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP7"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in ECG parameter: QTcF"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_8/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
.
<http://www.assero.co.uk/PREND#ae4844fc-04f5-4f09-8ee6-71fac5c86a43>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP8"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
.
<http://www.assero.co.uk/PREND#9d528894-b206-4dd0-8cfc-23970b7edf1c>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP9"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the DAD total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d952ef91-dff8-424d-b19a-c6c1e53177a4> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8b2b8b13-78e4-40a2-9ee8-ce89e8699197> ;
.